Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

China

Peking Union Medical College Hospital, Beijing, Beijing Municipality

Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong

Henan Provincial People's Hospital, Zhengzhou, Henan

Xiangya Hospital Central South University, Changsha, Hunan

Jiangsu Province Hospital, Nanjing, Jiangsu

The First Hospital of China Medical University, Shenyang, Liaoning

Xijing Hospital, Xi'an, Shaanxi

Yan'an University Affiliated Hospital, Yan’an, Shaanxi

Sichuan Provincial People's Hospital, Chengdu, Sichuan

Tianjin Third Central Hospital, Tianjin, Tianjin Municipality

The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan

Tianjin Medical University General Hospital, Tianjin